Profil bibliographique

Albana Liço

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

28Publications signalées

298Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

Multiple Myeloma Research and TreatmentsAcute Myeloid Leukemia ResearchChronic Lymphocytic Leukemia ResearchMyeloproliferative Neoplasms: Diagnosis and TreatmentProtein Degradation and Inhibitors

Publications récentes

2026 articleOpenAlex

Real‐world outcomes of venetoclax plus hypomethylating agents in unfit acute myeloid leukaemia: Results of the GIMEMA AML2320 trial

Raffaele Palmieri, Alfonso Piciocchi, Stefano Soddu, Marco Frigeni et autres

0 citationsBritish Journal of Haematology

Accès ouvert 2025 articleOpenAlex

Gilteritinib in FLT3‐mutated acute myeloid leukemia: A real‐world Italian experience

Roberto Cairoli, Lorenzo Castello, Silvia Imbergamo, Elisabetta Pierdomenico et autres

7 citationsCancer

2025 articleOpenAlex

Real-world study in steroid-refractory acute graft versus host disease: Comparison of efficacy and tolerability of ruxolitinib alone or ruxolitinib in association with extracorporeal photopheresis or extracorporeal photopheresis monotherapy

Marta Lisa Battista, Gabriele Facchin, Maria De Martino, Patrizia Chiusolo et autres

0 citationsBone Marrow Transplantation

Accès ouvert 2024 articleOpenAlex

Efficacy and safety of venetoclax plus hypomethylating agents in relapsed/refractory acute myeloid leukemia: a multicenter real-life experience

Francesco Angotzi, Federica Lessi, Matteo Leoncin, Carla Filì et autres

12 citationsFrontiers in Oncology

Accès ouvert 2024 articleOpenAlex

A real‐world retrospective–prospective analysis of efficacy and safety of combined ixazomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma: The northern Italy experience

Anna Furlan, Michele Cea, Laura Pavan, Mónica Galli et autres

4 citationsCancer Medicine

Accès ouvert 2023 conference-abstractOpenAlex

Sequential Chemotherapy and Blinatumomab to Improve Minimal Residual Disease in Adult Ph- B-Lineage Acute Lymphoblastic Leukemia. Final Results of the Phase II Gimema LAL2317 Trial

Sabina Chiaretti, Irene Della Starza, Alessandra Santoro, Orietta Spinelli et autres

28 citationsBlood

Accès ouvert 2023 articleOpenAlex

A real-life study of daratumumab-bortezomib-dexamethasone (D-VD) in lenalidomide exposed/refractory multiple myeloma patients: a report from the Triveneto Myeloma Working Group

Gregorio Barilà, Francesca Maria Quaglia, Anna Furlan, Norbert Pescosta et autres

5 citationsAnnals of Hematology

Accès ouvert 2023 articleOpenAlex

P549: EFFICACY AND TOXICITY OF CPX-351 IN PATIENTS WITH HIGH-RISK ACUTE MYELOID LEUKEMIA (AML): THE MULTICENTER REAL-WORLD EXPERIENCE FROM THE “ITALIAN TRIVENETO REGISTRY”.

Gian Luca Morelli, Carla Filì, Endri Mauro, Anna Maria Scattolin et autres

0 citationsHemaSphere

Accès ouvert 2023 articleOpenAlex

P970: A REAL-WORLD RETROSPECTIVE-PROSPECTIVE ANALYSIS OF EFFICACY AND SAFETY OF COMBINED IXAZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: THE NORTHERN ITALY EXPERIENCE

Anna Furlan, Michele Cea, Renato Zambello, Laura Pavan et autres

0 citationsHemaSphere

Accès ouvert 2023 articleOpenAlex

P49 A REAL-WORLD RETROSPECTIVE-PROSPECTIVE ANALYSIS OF EFFICACY AND SAFETY OF COMBINED IXAZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: THE NORTHERN ITALY EXPERIENCE

Anna Furlan, Michele Cea, Renato Zambello, Laura Pavan et autres

0 citationsHemaSphere

Accès ouvert 2022 erratumOpenAlex

Corrigendum to “Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience” [Leukemia Res. 114 (March 2022) 106803]

Eleonora De Bellis, Silvia Imbergamo, Anna Candoni, Albana Liço et autres

0 citationsLeukemia Research

Accès ouvert 2022 articleOpenAlex

Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience

Eleonora De Bellis, Silvia Imbergamo, Anna Candoni, Albana Liço et autres

29 citationsLeukemia Research

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.